Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

Clicks: 407
ID: 266702
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #9 of 86 articles by views in JAMA network open

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
ClinicalTrials.gov Identifier: NCT04323527.
Reference Key
mgs2020jamaeffect Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Borba MGS;Val FFA;Sampaio VS;Alexandre MAA;Melo GC;Brito M;Mourão MPG;Brito-Sousa JD;Baía-da-Silva D;Guerra MVF;Hajjar LA;Pinto RC;Balieiro AAS;Pacheco AGF;Santos JDO;Naveca FG;Xavier MS;Siqueira AM;Schwarzbold A;Croda J;Nogueira ML;Romero GAS;Bassat Q;Fontes CJ;Albuquerque BC;Daniel-Ribeiro CT;Monteiro WM;Lacerda MVG; ;;
Journal JAMA network open
Year 2020
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/32330277
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE covid-19 sars-cov-2 humans pubmed abstract nih national institutes of health national library of medicine pandemics research support non-u.s. gov't adult female male aged middle aged Clinical Trial Randomized Controlled Trial Double-Blind Method anti-bacterial agents / therapeutic use pneumonia disease outbreaks betacoronavirus dose-response relationship drug antiviral agents / administration & dosage antiviral agents / therapeutic use* viral / drug therapy* brazil phase ii antiviral agents / adverse effects chloroquine / therapeutic use azithromycin / therapeutic use coronavirus infections / drug therapy* pmid:32330277 doi:10.1001/jamanetworkopen.2020.8857 mayla gabriela silva borba fernando fonseca almeida val clorocovid-19 team chloroquine / administration & dosage chloroquine / adverse effects chloroquine / analogs & derivatives* oseltamivir / therapeutic use tertiary care centers

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.